Global Oncology Market Estimated to Reach US$ 137.99 Mn by 2021, Driven by Advances in Personalized Medicine and Immuno - Oncology

Absolute Markets Insights offers its latest published report ‘Oncology Market By Therapeutic Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, Others); By Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Skin Cancer, Lung Cancer, Other); By Regional Outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 – 2026.’ The author of the report analyzed that the Global Oncology Market accounted for US$ 93.60 Bn in 2016. Oncology is the branch of medicine that deals with the treatment of cancers and tumors. At present, a significant portion of the total patient population is affected with cancer. A large number of research and development projects are underway in order to innovate cancer drugs for various cancer types including blood, breast, lung, skin, and others.

Purchase the complete report titled “Oncology Market - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018-2026” at https://www.absolutemarketsinsights.com/checkout?id=12

From the period of 2011 to 2016, cancer treatment has witnessed the launch of 68 novel therapies. These developments have led to improved patient treatment outcomes, especially for metastatic disease, and have led to an increased number of patients receiving the treatment. There is tremendous inflow of novel therapies and increasing use of diagnostic testing. The oncology pipeline is robust with over 600 molecules in late stage development. The focus on this market is expected to remain high over the next decade driven by the ongoing research and development and remaining unmet need. The pipeline of oncology drugs in clinical development has expanded by 45% over the past ten years; 87% of the late stage pipeline are targeted therapies which include small molecule protein kinase inhibitors and biologic monoclonal antibodies. However, the high cost of drug development and the risk of drug failure remains a prominent threat which can hamper the growth of global oncology market.

Request A Sample at https://www.absolutemarketsinsights.com/request_sample.php?id=12

Chemotherapy is Anticipated to be the Dominant Segment During the Forecast Period, 2018-2026
Among the therapeutic treatment, chemotherapy held the largest share in global oncology market. Chemotherapy treatment prevents the cancer cells from growing and dividing as it grows faster than normal healthy cells. Chemotherapy is a core treatment for cancers of all types, at various stages. However, immunotherapy is anticipated to be the fastest growing market due to various advancements in immuno-oncology.

North America to Remain the Dominant Region due to the Availability of Innovative Treatments in this Region
North America represents the largest market for oncology led by high growth in the U.S. There has been a rise in per capita spending on the drugs in the U.S. in the past five years. The availability of newly launched agents differs substantially by geography, with the highest number of novel agents being available in the United States. This has led to the tremendous growth of oncology market in this region.

Global Oncology Market is Fragmented with the Presence of Number of Global and Regional Players.
Some of the primary participants of global market are Roche, Novartis, Celgene, Bristol Myers Squibb, Johnson & Johnson, Pfizer, Eli Lilly, AstraZeneca, AbbVie, Incyte, Eisai, Sanofi and Merck & Co amongst others.
In June 2016, Merck & Co., Inc. along with Bristol-Myers Squibb Company developed new molecules for the treatment and management of multiple ailments of oncology. The companies have launched molecules in order to treat and cure advanced bladder cancer.

For More Inquire At https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=12

• Oncology Market – By Therapeutic Treatment
o Chemotherapy
o Targeted Therapy
o Immunotherapy
o Hormonal Therapy
o Radiation Therapy
o Others

• Oncology Market – By Cancer Type
o Blood Cancer
o Breast Cancer
o Prostate Cancer
o Skin Cancer
o Lung Cancer
o Other

• Market By Region
o North America
 U.S.
 Rest of North America
o Europe
 France
 The UK
 Spain
 Germany
 Italy
 Rest of Europe
o Asia Pacific
 China
 Japan
 India
 Southeast Asia
 Rest of Asia Pacific
o Middle East and Africa
 GCC Countries
 Southern Africa
 Rest of Middle East and Africa
o Latin America
 Brazil
 Rest of Latin America

Absolute Markets Insights is a global market research company taking into account leading businesses, colleges, universities, non-profit organizations, and government foundations. Absolute Markets Insights is dedicated to presenting you an ideal blend of data parameters. Our reports depend on the research and analysis that covers a magnitude of factors, for example, industry research, market sizing and forecasts, technological advancements, innovation trends, financial growth, pricing trends, competitive insights, and an in-depth study of market segments.

Our analysts are focused on providing autonomous experiences, by helping you execute better strategies with unbiased insights and conclusions, consistent specifics, and right responses to every one of the inquiries you may have. We serve customers in every aspect of the strategy, including sustainability trends, customer insights, technology evolution, distribution channel assessment, product development, exploring new markets and taking advantage of lucrative growth opportunities.

Contact Us:
Shreyas Tanna
Absolute Markets Insights
https://www.absolutemarketsinsights.com/
sales@absolutmarketsinsights.com
+91-7400-24-2424

This release was published on openPR.